Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple SclerosisGOLD, Ralf; KAPPOS, Ludwig; DAWSON, Katherine T et al.The New England journal of medicine. 2012, Vol 367, Num 12, pp 1098-1107, issn 0028-4793, 10 p.Article

Intrathecal baclofen in multiple sclerosis: Too little, too late?ERWIN, April; GUDESBLATT, Mark; ZAFFARONI, Mauro et al.Multiple sclerosis. 2011, Vol 17, Num 5, pp 623-629, issn 1352-4585, 7 p.Article

Platelet-derived growth factor-producing cells immortalized from rat mesencephalon with SV40 large T antigen transduced by an AAV vectorPHILLIPS, André W; PEISU ZHANG; TRUCKENMILLER, Mary Ellen et al.Restorative neurology and neuroscience. 2003, Vol 21, Num 1-2, pp 1-10, issn 0922-6028, 10 p.Article

Efficacy of Natalizumab Therapy in Patients of African Descent With Relapsing Multiple Sclerosis: Analysis of AFFIRM and SENTINEL DataCREE, Bruce A. C; STUART, William H; TORNATORE, Carlo S et al.Archives of neurology (Chicago). 2011, Vol 68, Num 4, pp 464-468, issn 0003-9942, 5 p.Article